Peptivo review

The terms list semaglutide at $179 for the first-month package and $179 for follow-up, with tirzepatide at $279 for each. The homepage says final pricing, cadence and inclusions vary by plan. Confirm that those terms apply to your actual prescription and renewal; the package list does not establish every dose or current offer.

The terms show $349 and $449 as original reference prices for semaglutide and tirzepatide. They separately state follow-up packages at $179 and $279. Those reference figures should not be described as renewal charges, although your actual plan still needs to confirm its own billing terms.

For each, the terms list a $99 first-month package followed by a $199 follow-up package. That differs from the semaglutide and tirzepatide entries, whose initial and follow-up figures match. Confirm the formulation, quantity and billing cadence rather than extending one product's promotion to another.

The terms generally make prescription orders nonrefundable once the initial medical intake is submitted. They permit refunds for initial provider-determined medical disqualification, unless relevant history was misrepresented, and for billing errors. Eligible requests must be made in writing within 28 days of payment; canceling after a charge does not by itself qualify.

The terms describe consultation, prescription, medication, shipping and ongoing medical support if needed. The new homepage says exact inclusions vary and supplies may be part of a plan. Match that list to the actual quote, including any testing or supplies, before treating it as a complete treatment total.

The homepage labels treatment routes as illustrative concept options and the portraits and scenarios as illustrative perspectives. They do not establish a currently available formulation, a named treating clinician or patient outcomes. A provider decides whether any prescription is appropriate, and the assigned pharmacy still needs confirmation.